Eugenia Levi, PharmD

Dr Levi is our Vice President of Medical Affairs.

She brings more than 10 years of experience in strategic drug development and clinical adoption of novel therapies in immunology. Most recently, she served as Head of Global Medical Affairs for COSENTYX® at Novartis, where she led overall medical strategy for multiple indications of COSENTYX, including the launch in hidradenitis suppurativa. Earlier, she held roles in US and Global Medical Affairs at Celgene, where she worked on launch and post-launch medical strategies for OTEZLA®, and at LEO Pharma, launching products in multiple dermatology indications.

She earned her Doctor of Pharmacy degree from Ernest Mario School of Pharmacy, where she also served as an Assistant Clinical Professor prior to transitioning to the pharmaceutical industry.